New Market Research Report: Osteoporosis Drugs Market in the APAC Region 2015-2019

From: Fast Market Research, Inc.
Published: Thu Jan 01 2015


Osteoporosis is a disease that reduces of the mass and density of bone, and results in increased risk of fracture. In this disease, the risks related to fracture increases because of the increased permeability of the bones. Often, there are no symptoms observed until the first fracture occurs. Increase in age, low body weight, low sex hormones or menopause, and smoking are some of the risk factors associated with this disease.

TechNavio's analysts forecast the Osteoporosis Drugs market in APAC to grow at a CAGR of 4.73 percent over the period 2014-2019.

Covered in this Report

The Osteoporosis Drugs market in APAC can be divided into two segments: Antiresorptives and Anabolics. This report covers the present scenario and the growth prospects of the Osteoporosis Drugs market in APAC for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various osteoporosis drugs that are available in the market.

Full Report Details at
- http://www.fastmr.com/prod/933083_osteoporosis_drugs_market_in_the_apac_region.aspx?afid=301

TechNavio's report, the Osteoporosis Drugs market in APAC 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Osteoporosis Drugs market in APAC landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

* Amgen
* Eli Lilly
* Merck
* Novartis

Other Prominent Vendors

* F. Hoffmann La Roche
* GlaxoSmithKline
* Jiangsu Hengrui Medicine
* Pfizer Inc.
* Qingdao Chiatai Haier Pharmaceutical  

Market Driver

* Increasing Global Aging Population
* For a full, detailed list, view our report

Market Challenge

* Multiple Patent Expiries
* For a full, detailed list, view our report

Market Trend

* Increasing Awareness of Bone Health Education
* For a full, detailed list, view our report

Key Questions Answered in this Report

* What will the market size be in 2018 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned in this Report: Amgen, Eli Lilly, Merck, Novartis, F. Hoffmann La Roche, GlaxoSmithKline, Jiangsu Hengrui Medicine, Pfizer Inc., Qingdao Chiatai Haier Pharmaceutical

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Global Osteoporosis Drugs Market 2014-2018
- Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014
- Global Generic Drugs Market 2014-2018
- Global ADHD Drugs Market 2014-2018
- Global Pain Management Drugs Market 2014-2018
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »